|Bid||3,820.00 x 51000|
|Ask||3,940.00 x 53800|
|Day's range||3,826.00 - 3,880.00|
|52-week range||3,603.50 - 5,377.00|
|PE ratio (TTM)||51.43|
|Earnings date||27 Oct 2017|
|Dividend & yield||0.26 (0.51%)|
|1y target est||70.24|
Bilaal Mohamed believes this hidden gem could help you on the road to riches.
Shire was the seventh-largest holding in Cooperman's Omega Advisors’ portfolio in 2Q17, representing nearly 3.5% of total holdings.
Categories: Europe Value Analsysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Shire Plc a score of 47. Our analysis is based on comparing Shire Plc with the following peers – GlaxoSmithKline plc, Hikma Pharmaceuticals Plc, AstraZeneca PLC and Pfizer Inc. (GSK-GB, HIK-GB, AZN-GB and PFE-SE). Investment Outlook Shire Plc has a fundamental score of 47 and has a ... Read more (Read more...)